Consultation: Harmonised classification and labelling

  • (3aS,5S,6R,7aR,7bS,9aS,10R,12aS,12bS)-10-[(2S,3R,4R,5R)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-5,6-dihydroxy-7a,9a-dimethylhexadecahydro-3H-benzo[c]indeno[5,4-e]oxepin-3-one; 24-epibrassinolide
  • acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N’-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
  • carbendazim (ISO); methyl benzimidazol-2-ylcarbamate
  • cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; cypermethrin cis/trans +/- 40/60
  • Tetrafluoroethylene
  • thiamethoxam (ISO); 3-(2-chloro-thiazol-5- ylmethyl)-5- methyl[1,3,5]oxadiazi nan-4-ylidene-N- nitroamine

View further information. 

Deadline: 22 March 2019

Source: European Chemicals Agency

 

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. Cookies help you create your Policy Newsfeed for example. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close